NLS Pharmaceutics
Pre-clinicalA Swiss biopharmaceutical company developing novel treatments for central nervous system disorders.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $15M
About
A Swiss biopharmaceutical company developing novel treatments for central nervous system disorders.
Small Molecules
Funding History
2Total raised:$15M
PIPE$5MMar 15, 2022
IPO$10MJan 29, 2021